ID
IDT.AU IDT Australia Ltd
- Market cap
- AUD 18.9M
- P/E
- -
- P/B
- 0.99x
- ROE
- -14.3%
- Dividend yield
- -
- Fundamental score
- 1.8/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is IDT.AU undervalued?
Graham numberThe Graham number of IDT Australia Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
IDT Australia Ltd fundamental analysis
8 of 21 checks passedROE 0/2
Low return on equity (-14.3%), below 10%.
ROA 1/1
Return on assets (-7.8%) is above the industry median (-8.9%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (64.5%) is above the industry median (42.8%).
Revenue Growth 2/2
Revenue grew 43.2% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (56.9%), up to 100%.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 2/2
Cash covers 10.3 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (1.0x) is below the industry median (2.0x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
IDT Australia Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About IDT Australia Ltd
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers integrated services, including development, analytical testing, clinical packaging; and microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides formulation and manufacture of speciality orals (medicina…
Full company profileIDT Australia Ltd financial statements
IDT Australia Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 9.54M | 12.9M | 12.1M | 14.1M | 16.0M | 12.1M | 6.94M | 13.2M | 19.8M | 20.4M |
| Gross Profit | 7.34M | 10.5M | 9.51M | 3.37M | 4.88M | 2.82M | -3.53M | 10.4M | 9.69M | 4.30M |
| Operating Income | -7.46M | -4.86M | -5.81M | -1.31M | 4.03M | 567K | -7.96M | -6.85M | -6.31M | -1.65M |
| EBITDA | -5.05M | -15.9M | -3.58M | 721K | 2.75M | -340K | -8.83M | -5.56M | -6.54M | -743K |
| Net Income | -773K | -17.0M | -6.08M | -1.92M | 2.10M | -1.16M | -8.50M | -5.41M | -8.06M | -2.72M |
| EPS | 0.00 | -0.07 | -0.02 | -0.01 | 0.01 | 0.00 | -0.03 | -0.02 | -0.02 | -0.01 |
| Balance Sheet | ||||||||||
| Total Assets | 58.1M | 38.9M | 31.2M | 28.6M | 34.1M | 30.1M | 28.3M | 31.4M | 36.9M | 34.9M |
| Total Liabilities | 9.20M | 6.46M | 6.19M | 5.29M | 6.51M | 3.46M | 4.15M | 7.93M | 15.0M | 15.9M |
| Shareholders' Equity | 48.9M | 32.5M | 25.0M | 23.3M | 27.6M | 26.6M | 24.1M | 23.4M | 21.9M | 19.0M |
| Cash & Short-term Investments | 8.42M | 14.0M | 9.50M | 6.86M | 6.93M | 9.21M | 4.43M | 904K | 4.11M | 2.52M |
| Total Debt | 664K | 542K | 9.00K | 5.00K | 766K | 881K | 740K | 4.47M | 10.4M | 10.8M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 2.02M | -1.63M | -1.52M | -1.89M | 370K | 2.86M | -7.90M | -9.60M | -6.25M | 1.07M |
| Capital Expenditure | 1.77M | 918K | 1.14M | 761K | 526K | 912K | 522K | 694K | 1.30M | 1.31M |
| Free Cash Flow | 253K | -2.55M | -2.66M | -2.65M | -156K | 1.95M | -8.42M | -10.3M | -7.55M | -243K |
| Ratios | ||||||||||
| ROE | -1.6% | -52.3% | -24.3% | -8.2% | 7.6% | -4.4% | -35.2% | -23.1% | -36.8% | -14.3% |
| ROA | -1.3% | -43.6% | -19.5% | -6.7% | 6.2% | -3.9% | -30.0% | -17.3% | -21.8% | -7.8% |
| Net Profit Margin | -8.1% | -131.7% | -50.1% | -13.6% | 13.2% | -9.6% | -122.5% | -40.9% | -40.8% | -13.3% |
| Debt to Equity | 0.01x | 0.02x | 0.00x | 0.00x | 0.03x | 0.03x | 0.03x | 0.19x | 0.48x | 0.57x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
IDT Australia Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Apr 12, 2010
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | AUD 2.88M | 0.01 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.1:1 on Apr 16, 2010.
Who owns IDT Australia Ltd
- Insiders 20.74%
- Institutions 31.20%
- Public & others 48.06%
- Shares outstanding 430M
- Free float 292M
IDT Australia Ltd company profile
- Company name
- IDT Australia Ltd
- Ticker
- IDT.AU
- ISIN
- AU000000IDT0
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- June
- Address
- 45 Wadhurst Drive, Boronia, VIC, Australia, 3155
- Phone
- 61 3 9801 8773
- Website
- idtaus.com.au
About IDT Australia Ltd
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers integrated services, including development, analytical testing, clinical packaging; and microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides formulation and manufacture of speciality orals (medicinal cannabis) and advanced therapies; psychedelics and medicinal cannabis; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
IDT Australia Ltd management
6- Mr. Mark Anthony Simari B.Acc, Dip FSExecutive Chairman & CEO · born 1969
- Mr. N. R. Malika PereraHead of Finance
- Mr. Jim SosicChief Operating Officer
- Ms. Paula CouttsHead of People & Safety
- Mr. Michael B. ThompsonDirector of Commercial & Business Development
- Mr. Robert CaunceDirector of Quality